Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Healthcare Biotechnology
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:GUD)

Knight to Present at the 2025 RBC Capital Markets Global Healthcare Conference in New York City

GlobeNewswire 3 days ago

Knight Therapeutics Reports First Quarter 2025 Results

GlobeNewswire 8 days ago

Knight Therapeutics Inc. announces voting results from the Annual General Meeting

GlobeNewswire 9 days ago

Knight Therapeutics Announces Relaunch of ONICIT® in Brazil and Mexico

GlobeNewswire 9 days ago

Notice of Knight Therapeutics' First Quarter 2025 Results Conference Call

GlobeNewswire May 1, 2025

Knight to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire April 29, 2025

Knight Therapeutics Inc. ranks on The Globe and Mail's sixth-annual Women Lead Here benchmark of executive gender diversity

GlobeNewswire March 28, 2025

Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico

GlobeNewswire March 26, 2025

Knight Therapeutics Reports Fourth Quarter and Year-End 2024 Results

GlobeNewswire March 20, 2025
View More News ››

Opinion & Analysis (TSX:GUD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:GUD)

any thoughts GPM gap and Argentina business

How are you thinking about the widening gap between IFRS GPM and adj GPM at 7% highest its been while inflation has slowed in...
curiousj - 1 day ago

Notice the large consolidated volume today so far

almost 400,000! & it's an up day.
GoldenInvestor - March 31, 2025

RE:RE:Notices of Reassessment

It's in the Q4/2024 report.
gudisgood - March 31, 2025

RE:Notices of Reassessment

Could you please share the source of the information. (About Feb 2026)
0xMaxF - March 31, 2025

Notices of Reassessment

The hearing date was moved to Feb 2026 and even that decision can be appealed. What a long process. :) Knight received notices of...
gudisgood - March 31, 2025

What Tim McElvaine is saying

Knight Therapeutics Inc. GUD-T is a stock we’ve owned for a couple of years but we recently tripled our position in it. It makes up...
wofats - March 28, 2025
View more Bullboard ››

Graphite One Inc.

Graphite One Inc.

Graphite One Inc. is a Canada-based company, which is focused on developing its Graphite One Project. The Graphite One ...
View More »